Cataract Surgery

Marta Belmonte-Grau, MD discusses the potential risk for posterior capsular rupture during cataract surgery.

Early experience with next-generation lens engenders positive perception.

Understanding nuances of reimbursement for novel, sustained-release ophthalmic drugs can help maximize the opportunity for patients and practice.

Advances help gain clearer image, enhancing decision-making process.

Substantial weight loss can help patients’ eye health, study results show.

Mark Gallardo, MD, reports 12-month outcomes of iStent inject® combined with cataract surgery in a predominantly Hispanic patient population with mild to moderate open-angle glaucoma (OAG) and comorbid cataract.

Physician offers practical advice for the use of systems.

Administration has minimal impact on patients’ perception of pain.

ASCRS has issued a statement calling on Aetna to drop a new prior authorization policy it implemented last week that delays cataract surgeries.

Technology enables physicians to provide and receive important information more quickly.

Much of today’s surgical refuse is due to the single use of virtually everything.

Investigators find little difference between the options.

In recognition of Cataract Awareness Month.

In recognition of Cataract Awareness Month.

In recognition of Cataract Awareness Month, Fasika Woreta, MD, MPH, discusses IOL options for cataract patients.

Retrospective review highlights the sustained efficacy of combination procedure.

In recognition of Cataract Awareness Month.

Lens option can correct for surgically induced astigmatism or an inaccurate position.

Bi-sign design compensates for aberrations resulting from misalignment.

Mark Packer, MD, offers personal insight in honor of Cataract Awareness Month.

Procedure can improve best-corrected visual acuity, enhancing quality of life for patients.

Short learning curve, significant clinical advantages make this a comfortable addition.

Surgeons learn that timing is everything when using technology.

Investigators find treatment is an option for treating open-angle glaucoma.

Johnson & Johnson Vision announced today that the FDA has granted 510(k) clearance and CE mark for its VERTIAST Vision System, a next-generation phacoemulsification innovation.

George Waring IV, MD serves as guest host for ‘History and Evolution of Contemporary Refractive Surgery’

An alternative to drops, the option provides consistent therapeutic levels.

The method by which sedation is applied to keep patients relaxed and comfortable throughout cataract surgery can be tailored similar to that of anesthesia — surgical anesthesia is not a one size fits all endeavor.

Several hundred genes are associated with congenital forms.